NCT02758041View on ClinicalTrials.gov

A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

February 28, 2017

Conditions
Facial Acne Vulgaris
Interventions
DEVICE

Sebacia Microparticles

Trial Locations (3)

1205

SKINPULSE Dermatology Laser & Beauty Center, Geneva

2400

Department of Dermatology, Bispebjerg Hospital, Univ of Copenhagen, Copenhagen

9220

Lasercenter North, Aalborg

All Listed Sponsors
lead

Sebacia, Inc.

INDUSTRY

NCT02758041 - A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris | Biotech Hunter | Biotech Hunter